These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 34381029)

  • 1. ICAM1 initiates CTC cluster formation and trans-endothelial migration in lung metastasis of breast cancer.
    Taftaf R; Liu X; Singh S; Jia Y; Dashzeveg NK; Hoffmann AD; El-Shennawy L; Ramos EK; Adorno-Cruz V; Schuster EJ; Scholten D; Patel D; Zhang Y; Davis AA; Reduzzi C; Cao Y; D'Amico P; Shen Y; Cristofanilli M; Muller WA; Varadan V; Liu H
    Nat Commun; 2021 Aug; 12(1):4867. PubMed ID: 34381029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived exosomal ICAM1 promotes bone metastasis of triple-negative breast cancer by inducing CD8+ T cell exhaustion.
    Chen M; Fu Z; Wu C
    Int J Biochem Cell Biol; 2024 Oct; 175():106637. PubMed ID: 39147124
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms underlying neutrophils adhesion to triple-negative breast cancer cells via CD11b-ICAM1 in promoting breast cancer progression.
    Yang C; Li L; Ye Z; Zhang A; Bao Y; Wu X; Ren G; Jiang C; Wang O; Wang Z
    Cell Commun Signal; 2024 Jun; 22(1):340. PubMed ID: 38907234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EGFR inhibition blocks cancer stem cell clustering and lung metastasis of triple negative breast cancer.
    Liu X; Adorno-Cruz V; Chang YF; Jia Y; Kawaguchi M; Dashzeveg NK; Taftaf R; Ramos EK; Schuster EJ; El-Shennawy L; Patel D; Zhang Y; Cristofanilli M; Liu H
    Theranostics; 2021; 11(13):6632-6643. PubMed ID: 33995681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The identification of a TNBC liver metastasis gene signature by sequential CTC-xenograft modeling.
    Vishnoi M; Liu NH; Yin W; Boral D; Scamardo A; Hong D; Marchetti D
    Mol Oncol; 2019 Sep; 13(9):1913-1926. PubMed ID: 31216110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intercellular Adhesion Molecule-1 as Target for CAR-T-Cell Therapy of Triple-Negative Breast Cancer.
    Wei H; Wang Z; Kuang Y; Wu Z; Zhao S; Zhang Z; Li H; Zheng M; Zhang N; Long C; Guo W; Nie C; Yang H; Tong A
    Front Immunol; 2020; 11():573823. PubMed ID: 33072116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homophilic CD44 Interactions Mediate Tumor Cell Aggregation and Polyclonal Metastasis in Patient-Derived Breast Cancer Models.
    Liu X; Taftaf R; Kawaguchi M; Chang YF; Chen W; Entenberg D; Zhang Y; Gerratana L; Huang S; Patel DB; Tsui E; Adorno-Cruz V; Chirieleison SM; Cao Y; Harney AS; Patel S; Patsialou A; Shen Y; Avril S; Gilmore HL; Lathia JD; Abbott DW; Cristofanilli M; Condeelis JS; Liu H
    Cancer Discov; 2019 Jan; 9(1):96-113. PubMed ID: 30361447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rhophilin-associated tail protein 1 promotes migration and metastasis in triple negative breast cancer via activation of RhoA.
    Liu Q; Huang X; Li Q; He L; Li S; Chen X; Ouyang Y; Wang X; Lin C
    FASEB J; 2020 Aug; 34(8):9959-9971. PubMed ID: 32427399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigating circulating tumor cells and distant metastases in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Ramani VC; Lemaire CA; Triboulet M; Casey KM; Heirich K; Renier C; Vilches-Moure JG; Gupta R; Razmara AM; Zhang H; Sledge GW; Sollier E; Jeffrey SS
    Breast Cancer Res; 2019 Aug; 21(1):98. PubMed ID: 31462307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. S100P and Ezrin promote trans-endothelial migration of triple negative breast cancer cells.
    Kikuchi K; McNamara KM; Miki Y; Iwabuchi E; Kanai A; Miyashita M; Ishida T; Sasano H
    Cell Oncol (Dordr); 2019 Feb; 42(1):67-80. PubMed ID: 30244410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic Glycoprotein Hyposialylation Promotes Chemotherapy Evasion and Metastatic Seeding of Quiescent Circulating Tumor Cell Clusters in Breast Cancer.
    Dashzeveg NK; Jia Y; Zhang Y; Gerratana L; Patel P; Shajahan A; Dandar T; Ramos EK; Almubarak HF; Adorno-Cruz V; Taftaf R; Schuster EJ; Scholten D; Sokolowski MT; Reduzzi C; El-Shennawy L; Hoffmann AD; Manai M; Zhang Q; D'Amico P; Azadi P; Colley KJ; Platanias LC; Shah AN; Gradishar WJ; Cristofanilli M; Muller WA; Cobb BA; Liu H
    Cancer Discov; 2023 Sep; 13(9):2050-2071. PubMed ID: 37272843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Testis Antigen Promotes Triple Negative Breast Cancer Metastasis and is Traceable in the Circulating Extracellular Vesicles.
    Kannan A; Philley JV; Hertweck KL; Ndetan H; Singh KP; Sivakumar S; Wells RB; Vadlamudi RK; Dasgupta S
    Sci Rep; 2019 Aug; 9(1):11632. PubMed ID: 31406142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PDSS1-Mediated Activation of CAMK2A-STAT3 Signaling Promotes Metastasis in Triple-Negative Breast Cancer.
    Yu TJ; Liu YY; Li XG; Lian B; Lu XX; Jin X; Shao ZM; Hu X; Di GH; Jiang YZ
    Cancer Res; 2021 Nov; 81(21):5491-5505. PubMed ID: 34408002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational ranking-assisted identification of Plexin-B2 in homotypic and heterotypic clustering of circulating tumor cells in breast cancer metastasis.
    Schuster E; Dashzeveg N; Jia Y; Golam K; Zhang T; Hoffman A; Zhang Y; Zheng C; Ramos E; Taftaf R; Shennawy LE; Scholten D; Kitata RB; Adorno-Cruz V; Reduzzi C; Spahija S; Xu R; Siziopikou KP; Platanias LC; Shah A; Gradishar WJ; Cristofanilli M; Tsai CF; Shi T; Liu H
    bioRxiv; 2023 Apr; ():. PubMed ID: 37090580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ICAM1 promotes bone metastasis via integrin-mediated TGF-β/EMT signaling in triple-negative breast cancer.
    Chen M; Wu C; Fu Z; Liu S
    Cancer Sci; 2022 Nov; 113(11):3751-3765. PubMed ID: 35969372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential functions of ERK1 and ERK2 in lung metastasis processes in triple-negative breast cancer.
    Gagliardi M; Pitner MK; Park J; Xie X; Saso H; Larson RA; Sammons RM; Chen H; Wei C; Masuda H; Chauhan G; Kondo K; Tripathy D; Ueno NT; Dalby KN; Debeb BG; Bartholomeusz C
    Sci Rep; 2020 May; 10(1):8537. PubMed ID: 32444778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MiR-148a functions to suppress metastasis and serves as a prognostic indicator in triple-negative breast cancer.
    Xu X; Zhang Y; Jasper J; Lykken E; Alexander PB; Markowitz GJ; McDonnell DP; Li QJ; Wang XF
    Oncotarget; 2016 Apr; 7(15):20381-94. PubMed ID: 26967387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis.
    Guo P; Yang J; Liu D; Huang L; Fell G; Huang J; Moses MA; Auguste DT
    Sci Adv; 2019 Mar; 5(3):eaav5010. PubMed ID: 30906868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor shedding and metastatic progression after tumor excision in patient-derived orthotopic xenograft models of triple-negative breast cancer.
    Razmara AM; Sollier E; Kisirkoi GN; Baker SW; Bellon MB; McMillan A; Lemaire CA; Ramani VC; Jeffrey SS; Casey KM
    Clin Exp Metastasis; 2020 Jun; 37(3):413-424. PubMed ID: 32335861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular Domains I and II of cell-surface glycoprotein CD44 mediate its
    Kawaguchi M; Dashzeveg N; Cao Y; Jia Y; Liu X; Shen Y; Liu H
    J Biol Chem; 2020 Feb; 295(9):2640-2649. PubMed ID: 31969394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.